R&D Issues Around HIV/AIDS

In the final post in a four-part series examining research and development issues around HIV, the Center for Global Health Policy's "Science Speaks" features a Q&A with Michael Johnson, deputy director of the Fogarty International Center at the National Institutes of Health (NIH), who discusses the aims of the Medical Education Partnership Initiative (MEPI), a $130 million program funded by PEPFAR and NIH, to bolster the health workforce and researchers in developing countries. As Johnson explains, "core funding for MEPI comes from PEPFAR, so a focus of the programs is HIV/AIDS. But there is also NIH funding to the projects, and this expands the program past HIV/AIDS into issues such as training in child and maternal health, cancer, heart disease, mental health, and emergency medicine" (Donnelly, 3/11). A second post features a Q&A with Kevin DeCock, director of the Center for Global Health at the CDC, who describes the ongoing studies of microbicides and the need to coordinate resources to maximize resources in this area (Donnelly, 3/10).

Back to other news for March 2011